The cost-effectiveness of depression treatment for co-occurring disorders: a clinical trial
Saved in:
Watkins, K.E., ET AL., The cost-effectiveness of depression treatment for co-occurring disorders: a clinical trial. Journal of Substance Abuse Treatment, Vol. 46, no. 2 (2014), p. 128-133.
Ref.
195673
Location:
SIIS R.991 Archivo
Palabras clave:
Análisis coste-eficacia, Diagnóstico dual, Drogodependencias, Efectos, Enfermedades mentales, Resultados, Terapia cognitiva, Tratamiento
Análisis coste-eficacia, Diagnóstico dual, Drogodependencias, Efectos, Enfermedades mentales, Resultados, Terapia cognitiva, Tratamiento
Similar Items: The cost-effectiveness of depression treatment for co-occurring disorders: a clinical trial
- SERVICE COSTS FOR WOMEN WITH CO-OCCURRING DISORDERS AND TRAUMA
- MINDFULNESS BASED TREATMENTS FOR CO OCCURRING DEPRESSION AND SUBSTANCE USE DISORDERS: WHAT CAN WE LEARN FROM THE BRAIN?
- TRAINING SUBSTANCE ABUSE TREATMENT STAFF TO CARE FOR CO-OCCURRING DISORDERS
- COGNITIVE BEHAVIOUR THERAPY (CBT) FOR THE TREATMENT OF CO-OCCURRING DEPRESSION AND SUBSTANCE USE: CURRENT EVIDENCE AND DIRECTIONS FOR FUTURE RESEARCH
- INTEGRATED TREATMENT FOR CO-OCCURRING DISORDERS: PERSONALITY DISORDERS AND ADDICTION
- Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: outcomes to 36-months